Page 1648 - Clinical Small Animal Internal Medicine

1586 Index

antiangiogenic therapy 1343–1344 antihistamines feline viral upper respiratory tract
VetBooks.ir canine myocardial disease atopic dermatitis 1409 forebrain disorders 783–784
disease 888
allergic skin diseases 1414
antiarrhythmics
formulation,
feline bronchial asthma 302
260–265
supraventricular arrhythmias miscellaneous skin diseases 1499 indications,
212–214, 217 antihypertensives 1105–1106, 1105 and side‐effects 1050
ventricular arrhythmias 200–204 antiinflammatory drugs fungal infections 986, 988–990,
antibacterials see antimicrobials; bacterial pyodermas 1467 992–993, 995, 997–999
individual classes/agents canine chronic bronchitis 308 gallbladder and extrahepatic biliary
antibiotic‐responsive diarrhea cutaneous adverse food ducts 725
(ARD) 627, 629, 636 reactions 1422 gastritis and gastric ulceration 554
antibiotics see antimicrobials; meningoencephalitis and hemotropic Mycoplasma 929
individual classes/agents meningomyelitis 800–801, 800 leptospirosis 947–948
antibody/antigen detection principles of therapy of dermatologic Lyme borreliosis 943
canine brucellosis 964 diseases 1399–1400 meningoencephalitis and
feline coronavirus 874 spotted fever and typhus group meningomyelitis 799, 799
feline leukemia virus 879–880 Rickettsia 939–940 miscellaneous skin diseases
fungal infections 986, 991–992, see also nonsteroidal 1497–1498, 1505–1506
994–995 antiinflammatory drugs motility disorders 577
leptospirosis 946–947 antimicrobials mycobacteriosis 982–983, 983
Lyme borreliosis 942 actinomycosis 978, 978 nocardiosis 978, 979–980
protozoal and arthropod‐borne anthrax 973–974, 973 nonhemotropic Mycoplasma,
infections 841–843 antimicrobial resistance 1030, Ureaplasma, and L‐form
protozoal and protozoa‐like 1045–1047 bacteria 934
infections 1004–1005 antimicrobial susceptibility optimizing antimicrobial
spotted fever and typhus group tests 845 therapy 1041, 1048
Rickettsia 939 atopic dermatitis 1410–1411 oral cavity and salivary glands 536,
tularemia 957 bacterial pyodermas 1462, 543–544
viral infections 843–844 1464–1470 otitis externa 1474–1476, 1476,
yersiniosis 953 bartonellosis 924 1478–1479, 1479
anticholinesterase inhibitors canine chronic bronchitis 310 parasitic skin diseases 1451–1460
(AChEI) 805–806 canine distemper virus 853–854 pleural effusion 340–341
anticoagulant rodenticide 439 canine herpesvirus 856 portosystemic shunts and
anticoagulants 321–322 canine infectious respiratory disease microvascular dysplasia 717
antidiuretic hormone (ADH) complex 1037 principles of therapy of dermatologic
heart failure 180 canine inflammatory liver diseases 1400–1402
hypothermia 432 disease 700–701, 703 prostatic diseases 1162, 1162
neuroendocrinology 39 canine parvovirus type 2 859 protozoal and protozoa‐like
pituitary‐dependent chronic enteropathies infections 1005–1006,
hyperadrenocorticism 52 627, 629, 636 1008–1009, 1014–1015,
polyuria and polydipsia 65, 67 cirrhosis 710 1018–1019
sodium and water coccidia 1024–1026, 1025 Q fever 960
homeostasis 1069–1076, 1072 common classes of antifungal salmon poisoning disease 914
syndrome of inappropriate agents 1049–1053, 1050 septic shock 427–428
antidiuretic hormone common classes of antimicrobial side‐effects and drug–drug
secretion 1214 agents 1041–1048, 1042–1043 interactions 1044
antiemetics 1167–1168 critical care setting 351 spotted fever and typhus group
antiepileptic drugs (AED) 761–766, dysbiosis 625 Rickettsia 939–940
767, 771 ehrlichiosis and anaplasmosis 911 surgical, traumatic, and bite wound
antifungals see antimicrobials; esophageal disorders infections 1030, 1032–1034
individual classes/agents 559–560 tetanus 968
antigen delivery systems exocrine pancreatic trauma and burns 454
1568–1569 insufficiency 588 urinary tract infections 1191–1195
antigenemia 878–880 feline inflammatory liver valvular heart disease 251
antigen‐presenting cells (APC) 1208, disease 690–691, 691 venomous snake bites 463
1567, 1569 feline leukemia virus 880 Wolbachia pipientis infection 918